Updated December 3, 2019

GW Pharmaceuticals PLC Sponsored ADR

U.K.-based GW Pharmaceuticals (“GW Pharma”) was formed in 1998 to develop cannabinoid based drugs. Much of its research and development efforts are focused on treatments for rare conditions stemming from epilepsy, glioma (a form of brain tumor), and schizophrenia.

Latest Trading

$114.79
0.96%
(-1.11)
Open 116.88
Previous Close 115.90
Today's Range
113.50 118.28
52 Week Range
95.71 196.00
Volume 580.21K
Equity Market Value $4.52B
Dividend Yield 0.00
Loading Chart...

Latest Trading

$9.70
0.00%
(0.00)
Open 9.70
Previous Close 9.70
Today's Range
9.70 10.00
52 Week Range
7.80 16.00
Volume 1.94K
Equity Market Value $382.20M
Dividend Yield 0.00
Loading Chart...